≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_TNK_LYMPHOMA_EXALLC for full statistics.

Mature T/NK-cell lymphomas, hilmo

DOID EFO Endpoint Browser

CD2_TNK_LYMPHOMA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C84
  • Cause of death: ICD-10 — C84

2 out of 7 registries used, show all original rules.

458

4. Check minimum number of events

None

458

5. Include endpoints

None

458

6. Filter based on genotype QC (FinnGen only)

458

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Lymphomata T-cellularia peripherica et cutanea

Similar endpoints

↥

List of similar endpoints to Mature T/NK-cell lymphomas, hilmo based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 458 166 292
Unadjusted period prevalence (%) 0.10 0.06 0.13
Median age at first event (years) 65.19 64.58 65.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
415
Matched controls
4150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
218.7
190
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
38.5
145.5
189
88
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
120.9
110
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.8
76.2
165
238
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
74.2
69
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
73.1
68
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
68.7
64
*
XW000
NOMESCO Finland
Bone marrow biopsy
15.9
59.1
100
81
L03AA02
ATC
filgrastim; parenteral
22.6
59.0
87
48
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.9
54.0
91
72
JN4BD
NOMESCO Finland
Extensive body CT
6.6
46.9
138
290
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.9
45.0
96
122
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.2
41.9
158
440
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
41.3
39
*
D07AB08
ATC
desonide; topical
6.8
40.6
114
220
L03AA13
ATC
pegfilgrastim; parenteral
15.8
39.7
66
49
WW500
NOMESCO Finland
Blood transfusion
10.9
38.6
77
85
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
38.1
36
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
35.1
36.6
47
15
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
17.5
36.5
58
38
PJA10
NOMESCO Finland
Exploration of lymph nodes
32.9
36.0
47
16
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
36.0
34
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
80.8
33.4
37
5
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
32.7
31
*
E0000UV
ATC
NA
3.6
32.5
227
1052
H02AB06
ATC
prednisolone; systemic
3.5
31.7
269
1436
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
56.1
30.9
36
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
30.8
108
265
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.8
30.4
55
49
D07AD01
ATC
clobetasol; topical
4.5
29.8
122
351
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
29.1
142
480
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
28.5
27
*
R50.9
ICD-10 Finland
Fever, unspecified
4.4
27.6
116
339
WW300
NOMESCO Finland
Transfer of autologic stem cells
103.7
27.0
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.8
26.8
71
122
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
25.3
26.6
37
16
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
25.3
26.6
37
16
L26
ICD-10 Finland
Exfoliative dermatitis
55.6
26.6
31
6
D07AC01
ATC
betamethasone; topical
3.2
26.4
206
984
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.2
25.7
65
104
D70.82
ICD-10 Finland
Drug-induced neutropenia
27.2
25.7
35
14
WW409
NOMESCO Finland
Other aferesis
265.3
24.9
25
*
D07AC13
ATC
mometasone; topical
3.3
24.8
167
712
C84.1
ICD-10 Finland
Sézary disease
+∞
24.2
23
*
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
24.2
23
*
D05BB02
ATC
acitretin; oral
11.1
22.9
44
44
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
55.3
22.3
26
5
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
66.3
22.1
25
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
41.1
22.0
27
7
E000001
ATC
NA
3.4
21.9
128
482
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
+∞
21.0
20
*
M04AA01
ATC
allopurinol; systemic
3.5
20.9
113
400
JN4AD
NOMESCO Finland
Body CT examination
4.7
20.6
75
186
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
16.6
19.6
31
20
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
27.6
19.4
26
10
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.9
18
*
A04AA02
ATC
granisetron; systemic, transdermal
5.8
18.8
55
106
127
Kela drug reimbursment
Transplant complication
14.6
18.1
30
22
JN6AD
NOMESCO Finland
CT of torso and neck
21.2
18.0
26
13
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.0
17.9
45
71
1XX25
NOMESCO Finland
NA
+∞
17.8
17
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
17.8
17
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.0
17.8
50
92
134
Kela drug reimbursment
General erythroderma
26.9
17.1
23
9
C10AB05
ATC
fenofibrate; oral
9.4
16.5
34
39
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.4
16.3
29
25
A04AA01
ATC
ondansetron; systemic, rectal
4.8
16.1
55
127
L01AA02
ATC
chlorambucil; oral
39.7
15.5
19
5
J05AB11
ATC
valaciclovir; oral
3.4
15.5
83
284
H02AB07
ATC
prednisone; oral
3.1
14.9
90
336
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.3
14.8
22
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
14.8
222
1387
E000002
ATC
NA
3.6
14.7
72
231
TQW80
NOMESCO Finland
Local dermatologic skincare
7.6
14.6
34
48
D02AE01
ATC
carbamide; topical
4.3
14.5
56
146
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.5
14.2
26
24
ZX120
NOMESCO Finland
Intravenous
3.5
13.8
69
225
ZX196
NOMESCO Finland
NA
+∞
13.6
13
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
35.3
13.6
17
5
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
41.5
13.2
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
12.9
81
311
H02AB09
ATC
hydrocortisone; systemic
7.7
12.7
29
40
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
12.6
12
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.6
12
*
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
133.9
12.5
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.7
12.2
24
26
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
12.1
30
47
E000006
ATC
NA
4.0
12.1
49
134
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
11.9
137
736
E000003
ATC
NA
5.1
11.8
37
78
A02BC02
ATC
pantoprazole; systemic
2.1
11.8
281
2059
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
19.6
11.7
17
9
WW402
NOMESCO Finland
Leucoferesis
123.3
11.5
12
*
XQ848
NOMESCO Finland
Dermatological photography
7.6
11.4
26
36
L03AA14
ATC
lipegfilgrastim; parenteral
10.0
11.4
22
23
D07AA02
ATC
hydrocortisone; topical
2.9
11.1
74
293
J02AC01
ATC
fluconazole; systemic
2.2
11.1
150
861
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.4
10.9
19
16
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
18.4
10.8
16
9
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
10.5
31
61
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.8
10.5
29
53
L41.8
ICD-10 Finland
Other parapsoriasis
112.8
10.5
11
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
112.8
10.5
11
*
D02AX
ATC
Other emollients and protectives
6.2
10.3
27
46
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.7
10.2
34
77
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
10.1
95
456
L20.0
ICD-10 Finland
Besnier prurigo
4.7
10.1
34
78
L04AD01
ATC
ciclosporin; systemic
7.0
10.1
24
36
J01MA12
ATC
levofloxacin; systemic
2.3
10.0
105
533
WZC30
NOMESCO Finland
Teaching
2.7
9.8
73
307
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
9.7
31
67
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.1
9.7
54
190
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.4
9.6
19
21
A07AA02
ATC
nystatin; oral
3.6
9.6
43
129
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
102.3
9.5
10
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.3
9.4
28
56
L41.4
ICD-10 Finland
Large plaque parapsoriasis
+∞
9.4
9
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
9.4
9
*
Z51.5
ICD-10 Finland
Palliative care
3.4
9.0
44
141
N02AA05
ATC
oxycodone; systemic
2.4
8.9
85
407
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.2
8.9
105
558
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.9
8.9
24
43
A05AA02
ATC
ursodeoxycholic acid; oral
9.8
8.9
17
18
TGC00
NOMESCO Finland
Bronchial lavation
5.5
8.8
25
48
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
51.1
8.7
10
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
51.1
8.7
10
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
51.1
8.7
10
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
51.1
8.7
10
*
B72
ICPC
Hodgkin Lymphoma
51.1
8.7
10
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
8.7
64
269
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
28.2
8.5
11
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
28.2
8.5
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.4
144
885
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
8.4
8
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
8.4
8
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
8.2
51
193
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
8.2
61
258
L04AA06
ATC
mycophenolic acid; systemic
7.1
8.2
19
28
D69.5
ICD-10 Finland
Secondary thrombocytopenia
34.1
8.1
10
*
H26.3
ICD-10 Finland
Drug-induced cataract
22.5
8.1
11
5
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.5
8.0
36
109
ZX112
NOMESCO Finland
Subcutaneous
6.8
8.0
19
29
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.3
7.9
20
33
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
81.5
7.4
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.4
99
552
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.4
120
719
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.0
7.4
17
25
TK800
NOMESCO Finland
Hemodialysis
5.3
7.3
21
41
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
7.3
7
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
7.3
7
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
7.3
7
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
7.3
7
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
7.3
7
*
H03AA01
ATC
levothyroxine sodium; systemic
2.1
7.3
96
530
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.4
7.2
64
297
H02AB02
ATC
dexamethasone; systemic
2.6
7.2
53
223
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
30.6
7.2
9
*
L30.3
ICD-10 Finland
Infective dermatitis
4.6
7.1
23
52
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.2
7.1
16
23
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.7
7.0
29
82
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.0
7.0
18
31
ZX108
NOMESCO Finland
Inhalation
11.2
6.8
12
11
E000007
ATC
NA
3.3
6.8
32
101
RS340
NOMESCO Finland
NA
40.7
6.8
8
*
J02AC03
ATC
voriconazole; systemic
40.7
6.8
8
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
40.7
6.8
8
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
17.0
6.8
10
6
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
6.7
42
158
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
6.7
102
596
JFB00
NOMESCO Finland
Partial resection of small intestine
6.1
6.7
17
29
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
12.5
6.6
11
9
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
6.6
57
261
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
10.3
6.6
12
12
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
6.6
37
131
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
70.9
6.4
7
*
GEA00
NOMESCO Finland
Mediastinoscopy
70.9
6.4
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
70.9
6.4
7
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
6.4
33
112
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
6.7
6.4
15
23
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.7
6.4
15
23
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.8
6.4
38
142
FM1FN
NOMESCO Finland
Heart function isotope examination
18.4
6.3
9
5
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
6.3
6
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
6.3
6
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
6.3
6
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
6.3
6
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
6.3
6
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
6.3
6
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
27.1
6.2
8
*
S18
ICPC
Laceration/cut
1.7
6.1
182
1312
D07XC01
ATC
betamethasone, combinations; topical
2.2
6.1
61
298
J01DB01
ATC
cefalexin; oral
1.8
6.1
322
2735

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
83
27
37.32
129.84
1.6
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
102
62
20.88
125.65
5.4
3.7
u/ml
29322.1
3128.4
—
28
8
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
118
6
263.88
120.01
1.9
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
72
20
42.53
117.42
2.3
2.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
80
33
29.16
115.45
3.4
1.9
e9/l
1.5
1.1
0.66
54
15
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
100
75
16.78
110.13
10.1
6.3
iu/ml
438.9
126.5
—
21
10
(40768443) Skin Pathology biopsy report
135
171
10.78
105.48
2.1
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
67
21
37.20
105.44
2.2
2.3
%
13.0
12.4
0.08
53
11
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
69
27
29.91
101.11
3.5
2.0
e6/l
556.9
569.2
0.03
55
22
(40768795) Lymph node Pathology biopsy report
76
40
22.58
99.24
1.7
1.2
—
—
—
0
0
(4035726)
182
353
7.90
98.42
2.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
143
216
9.17
96.54
1.6
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
66
28
27.37
93.81
3.6
2.0
e6/l
393.5
769.4
0.91
15
13
(3045142) Bone marrow Pathology biopsy report
72
54
15.63
78.49
1.6
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
177
442
5.90
71.30
2.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
155
349
6.20
69.77
2.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
160
375
6.02
68.88
1.9
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
75
84
10.48
62.85
2.3
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
66
72
10.54
56.20
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
65
72
10.36
54.70
1.6
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
283
1231
4.40
53.36
14.2
5.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
51
41
13.87
52.94
1.8
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
163
492
4.59
50.15
5.5
2.6
%
1.9
1.8
0.40
154
450
(3018010) Neutrophils/100 leukocytes in Blood
330
1689
4.41
47.53
14.3
5.8
%
56.5
58.2
1.65
325
1580
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
64
9.83
45.85
1.6
1.4
u/ml
179.6
97.8
—
10
13
(3013115) Eosinophils [#/volume] in Blood
345
1850
4.51
45.83
14.5
6.0
e9/l
0.2
0.2
0.22
325
1633
(3019198) Lymphocytes [#/volume] in Blood
341
1822
4.41
45.31
14.0
5.7
e9/l
1.7
1.9
0.85
322
1610
(3006315) Basophils [#/volume] in Blood
338
1797
4.36
45.18
13.9
5.6
e9/l
0.0
0.0
1.22
317
1564
(3001604) Monocytes [#/volume] in Blood
337
1789
4.35
45.12
13.9
5.6
e9/l
0.6
0.6
0.10
317
1544
(3017181) Myelocytes/100 leukocytes in Blood
118
299
4.97
44.77
7.5
4.2
%
0.8
0.8
0.05
65
101
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
24
16.68
43.02
4.6
2.9
%
34.5
44.6
—
10
8
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
65
100
7.41
41.57
4.1
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
127
362
4.47
41.29
5.1
2.8
e9/l
73.1
69.1
0.55
106
288
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
65
102
7.26
40.81
3.9
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
30
14
22.86
40.40
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
44
46
10.48
38.30
3.6
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
107
282
4.65
38.26
7.3
4.2
%
0.3
0.2
0.53
56
92
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
71
8.31
38.14
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
75
8.03
37.69
3.8
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
102
266
4.65
36.87
6.9
4.0
%
0.5
0.4
0.34
40
72
(3048929) Epstein Barr virus Ab [Presence] in Serum
59
96
6.91
35.69
1.5
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
41
44
10.14
34.97
3.8
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
36
32
12.12
34.86
1.5
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
36
33
11.75
34.17
3.0
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
347
2097
3.70
33.46
28.7
9.4
e9/l
3.8
4.2
3.09
326
1834
(3004809) Band form neutrophils/100 leukocytes in Blood
45
60
8.21
32.41
7.0
3.7
%
2.4
1.0
0.98
40
53
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
98
276
4.25
31.78
3.3
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
160
628
3.38
31.69
10.9
3.5
mmol/l
0.8
0.8
2.82
155
590
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
69
7.30
29.88
1.4
1.2
u/ml
351.8
265.6
0.63
30
37
(3026493) Urate [Moles/volume] in Serum or Plasma
209
987
3.06
29.84
7.2
2.9
umol/l
1709.7
7257.6
1.91
200
849
(3028026) IgM [Mass/volume] in Serum or Plasma
83
227
4.24
27.79
1.7
1.6
g/l
1.0
1.4
1.04
78
205
(3025159) Blasts/100 leukocytes in Blood
90
265
3.98
27.22
6.3
4.3
%
0.0
0.2
0.96
42
79
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
56
118
5.27
25.76
2.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
18
14.02
25.56
5.3
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
18
14.02
25.56
5.3
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
33
9.66
24.99
1.7
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
19
13.27
24.77
5.3
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
19
10
19.78
24.05
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
90
289
3.63
23.83
1.4
2.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
32
41
8.32
23.69
4.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
32
41
8.32
23.69
4.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
32
41
8.32
23.69
4.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
37
59
6.73
22.62
2.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
22
11.46
22.61
5.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
22
11.46
22.61
5.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
22
11.46
22.61
5.3
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
22
11.46
22.61
5.3
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
75
5.91
21.90
2.4
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
215
1167
2.59
21.78
12.4
4.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
18
11
16.99
21.22
3.8
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
143
4.41
21.17
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
193
3.90
20.66
1.8
1.9
g/l
1.7
1.6
0.28
59
170
(3024561) Albumin [Mass/volume] in Serum or Plasma
275
1709
2.52
20.44
12.8
4.8
g/l
33.0
35.1
6.93
266
1594
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
23
10.48
20.42
2.4
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
23
10.48
20.42
2.3
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
10
17.62
20.38
1.5
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
52
6.76
20.37
8.5
3.8
—
—
—
0
0
(44790049)
31
46
7.16
20.21
2.8
1.5
—
—
—
0
0
(44806118)
31
46
7.16
20.21
2.8
1.5
—
—
—
0
0
(44790047)
31
46
7.16
20.21
2.8
1.5
—
—
—
0
0
(44790048)
31
46
7.16
20.21
2.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
64
5.84
18.66
1.9
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
58
6.05
18.31
1.2
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
39
7.29
18.00
8.0
2.8
%
58.4
61.8
0.25
21
30
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
107
4.55
17.83
2.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
149
738
2.51
17.60
10.6
4.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
28
44
6.71
17.30
4.1
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
89
4.83
17.16
3.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
20
21
9.91
17.11
2.5
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
20
21
9.91
17.11
2.5
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
169
903
2.38
16.75
22.7
7.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
139
682
2.49
16.63
4.1
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
152
3.81
16.35
1.3
2.2
u/l
43.3
39.3
0.53
46
133
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
41
98
4.50
16.12
1.3
2.0
mg/l
12.9
12.8
0.02
34
91
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
48
6.15
15.90
2.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
121
570
2.53
15.68
2.4
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
42
6.50
15.64
1.8
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
101
438
2.68
15.49
2.2
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
292
2005
2.26
15.39
20.0
6.8
umol/l
11.3
11.8
0.26
286
1900
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
10
14.41
15.10
1.8
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
58
5.46
15.06
2.7
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
20
8
26.04
14.80
1.7
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
102
455
2.60
14.73
2.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
67
5.06
14.71
2.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
95
411
2.65
14.58
5.0
3.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
13
11.90
14.49
7.8
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
59
198
3.27
14.30
1.7
1.2
u/ml
2467.8
222.6
0.68
52
179
(3015377) Calcium [Moles/volume] in Serum or Plasma
207
1266
2.16
14.28
8.3
3.5
mmol/l
2.3
2.3
0.45
199
1104
(3021589) Normoblasts [#/volume] in Blood
243
1586
2.13
14.10
19.9
10.0
e9/l
0.0
0.0
0.47
210
1301
(3007164) IgA [Mass/volume] in Serum or Plasma
128
651
2.34
13.81
1.6
1.4
g/l
2.6
2.7
0.17
98
379
(21494434) Karyotype in Bone marrow
26
48
5.68
13.69
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
225
1442
2.10
13.52
3.1
2.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
69
4.75
13.27
5.3
3.6
%
53.7
58.8
1.20
31
69
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
456
2.49
13.26
9.6
3.0
umol/l
6.2
8.8
1.29
92
406
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
61
5.01
13.25
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
27
54
5.25
13.05
2.7
2.1
pg
34.6
33.5
0.87
27
54
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
47
5.57
12.91
4.1
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
27
7.30
12.79
8.0
4.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
36
94
4.07
12.61
1.4
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
99
469
2.42
12.42
3.1
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
49
5.34
12.35
4.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
49
5.34
12.35
4.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
49
5.34
12.35
4.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
49
5.34
12.35
4.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
50
5.23
12.08
4.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
472
2.37
11.80
3.3
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
53
187
3.07
11.78
1.9
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
16
7
23.61
11.64
2.1
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
267
1893
1.98
11.42
17.1
7.2
mmol/l
1.2
1.2
0.25
228
1581
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
148
3.26
11.23
2.7
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
92
443
2.35
11.04
1.5
1.3
titre
380.0
434.1
0.23
20
95
(3013707) Erythrocyte sedimentation rate by Westergren method
344
2686
2.13
11.01
7.3
4.2
mm/h
16.2
13.2
2.51
335
2449
(3035933) Granulocytes/100 leukocytes in Blood
13
14
9.53
10.81
2.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
7
22.09
10.74
2.1
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
43
143
3.21
10.54
1.6
2.9
g/l
0.5
1.1
0.50
38
128
(3028433) Virus identified in Specimen by Culture
13
15
8.89
10.28
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
33
96
3.63
9.94
1.5
4.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
26
6.34
9.52
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
73
338
2.38
9.50
3.2
1.9
nmol/l
372.9
380.8
0.11
68
310
(21494814) CD8 cells/100 lymphocytes in Specimen
14
8
18.00
9.45
1.9
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
14
20
7.19
9.33
1.6
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
240
1722
1.83
9.10
10.4
4.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
31
5.66
9.04
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
21
6.85
8.94
1.4
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
184
1223
1.84
8.90
7.4
2.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
78
382
2.26
8.90
6.1
3.8
mmol/l
1.2
1.9
0.71
66
299
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
131
3.07
8.77
1.5
4.5
mg/l
73.4
115.5
0.36
29
100
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
131
3.07
8.77
1.5
4.5
mg/l
55.8
32.0
1.19
28
103
(3042631) Mycobacterium sp identified in Specimen
22
52
4.39
8.75
2.0
3.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
166
2.83
8.67
1.5
2.5
g/l
4.3
3.7
0.87
33
122
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
240
1739
1.80
8.65
14.6
6.5
mmol/l
1.2
1.2
0.05
232
1558
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
167
2.81
8.57
1.5
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
167
2.81
8.57
1.5
2.5
g/l
7.2
7.3
0.17
33
128
(3012544) pH of Venous blood
79
396
2.20
8.50
6.0
3.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
157
2.84
8.41
1.5
2.6
g/l
3.3
3.2
0.21
33
123
(3032080) INR in Blood by Coagulation assay
231
1667
1.78
8.34
11.7
10.1
inr
1.2
1.3
0.58
57
449
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
23
6.25
8.23
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
5
22.48
8.05
2.6
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
11
14
8.03
8.02
5.7
5.7
%
51.1
46.6
0.18
11
14
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
101
3.22
7.86
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
123
744
1.89
7.85
9.0
3.3
mmol/l
2.5
2.5
1.31
115
660
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
169
2.70
7.84
5.3
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
32
5.14
7.71
1.4
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
195
2.57
7.71
6.3
3.9
mmol/l
24.0
24.0
0.00
47
175
(3002256) Pathology report gross observation
88
481
2.03
7.52
1.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
9
13.65
7.42
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
67
334
2.18
7.27
11.8
9.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
127
793
1.83
7.27
2.6
1.7
mg/l
1.9
1.3
1.58
112
628
(3018418) pH of Serum or Plasma
171
1169
1.74
7.18
10.6
4.3
ph
7.4
7.4
0.74
37
222
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
35
133
2.77
6.81
1.5
1.6
—
231.4
—
0
7
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
24
5.55
6.80
1.2
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
285
2258
1.69
6.76
9.3
5.2
mmol/l
6.6
6.8
0.97
273
2128
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
142
934
1.75
6.76
6.7
2.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
25
5.32
6.52
1.3
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
89
518
1.89
6.28
16.7
6.9
mmol/l
104.4
104.1
0.28
89
504
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
52
3.77
6.26
1.3
1.7
g/l
0.8
0.9
0.07
11
41
(3003694) ABO and Rh group [Type] in Blood
137
909
1.72
6.25
1.6
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
105
2.88
6.17
1.8
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
106
2.85
6.07
1.8
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
107
2.83
5.97
1.8
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
149
2.54
5.95
2.5
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
6
15.26
5.92
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
103
2.83
5.80
1.4
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
60
3.44
5.79
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
24
5.11
5.77
1.3
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
17
5.99
5.65
1.2
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
17
5.99
5.65
2.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1439
1.60
5.62
4.3
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
253
2.14
5.60
2.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
21
5.34
5.55
2.4
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
66
365
1.94
5.40
3.0
2.3
g/l
0.2
0.2
0.27
61
338
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
34
4.22
5.39
2.6
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
271
2.08
5.38
7.4
3.5
mmol/l
2.3
1.9
0.36
45
198
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
30
4.43
5.33
1.2
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
8
11.44
5.31
1.1
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
22
5.10
5.28
2.4
1.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
0
+∞
5.22
2.6
0.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
167
1212
1.59
5.21
4.3
3.3
e6/l
15.2
116.4
1.23
132
946
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
35
4.09
5.20
1.3
1.2
g/l
0.3
0.3
—
9
26
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
35
4.09
5.20
1.3
1.2
g/l
6.6
7.0
—
9
28
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
35
4.09
5.20
1.3
1.2
g/l
3.0
2.3
—
9
27
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
40
186
2.26
5.14
8.4
4.0
mmol/l
25.3
25.0
0.16
40
175
(3009343) pH of Capillary blood
55
291
2.01
5.10
7.3
3.4
ph
7.4
7.4
—
6
28
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
6
13.54
5.09
1.1
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
27
4.54
5.06
2.3
1.7
—
—
—
0
0
(4062490)
14
36
3.98
5.02
1.3
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
286
2.01
4.99
3.4
4.1
ng/l
100.5
87.0
0.32
49
257
(3019309) Folate [Moles/volume] in Red Blood Cells
115
777
1.64
4.75
1.8
1.8
nmol/l
967.5
1206.1
2.08
94
575
(3004616) Nuclear Ab [Presence] in Serum
14
38
3.77
4.68
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
43
3.57
4.65
1.5
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
8
10.15
4.53
2.5
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
151
2.28
4.42
1.8
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
135
963
1.57
4.42
2.6
2.1
mg/l
3.4
3.2
0.39
125
821
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
158
1173
1.53
4.30
7.6
3.3
u/l
35.8
33.6
0.42
151
1118
(3026782) Osmolality of Urine
115
796
1.59
4.26
3.5
2.9
mosm/kgh2o
561.7
574.2
0.29
100
678
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
13
36
3.69
4.23
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
113
781
1.59
4.21
4.5
3.9
ng/l
165.4
273.4
0.46
95
647
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
13
7.03
4.18
3.0
6.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
149
1099
1.53
4.16
4.1
3.2
e6/l
0.2
0.5
3.33
119
831
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1438
1.49
4.14
3.8
2.7
ug/l
657.6
162.0
3.23
172
1309
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
160
1199
1.51
4.14
3.6
2.5
u/l
71.3
56.4
0.33
150
1112
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
185
1430
1.49
4.12
2.4
2.2
nmol/l
75.1
76.4
0.25
169
1246
(3017704) Immunofixation for Urine
10
23
4.42
4.11
1.1
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
42
3.41
4.07
1.6
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
7
10.13
4.02
1.3
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
43
3.33
3.94
1.6
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
65
2.84
3.90
1.7
1.4
miu/ml
72.2
274.9
—
5
25
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
133
2.26
3.89
2.7
2.8
u/ml
0.3
0.3
0.03
17
70
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
558
1.64
3.88
2.8
2.5
%
23.5
22.3
0.24
73
488
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
11
7.38
3.87
1.3
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
224
1.96
3.83
8.3
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
141
1044
1.51
3.82
4.1
3.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
5
12.13
3.77
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
5
12.13
3.77
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
22
91
2.49
3.69
1.5
1.2
—
2.5
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
79
2.60
3.68
1.5
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
87
583
1.61
3.66
2.7
2.4
g/l
2.2
2.3
0.63
81
539
(3019225) pH of Specimen
61
374
1.73
3.59
13.3
4.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
63
2.76
3.53
2.1
1.4
iu/l
25.1
28.1
0.13
17
51
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
13
6.24
3.51
1.3
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
13
6.24
3.51
2.3
1.5
umol/l
27.6
29.2
—
8
13
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
13
6.24
3.51
1.3
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
13
6.24
3.51
3.7
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
115
829
1.52
3.50
3.5
2.6
e6/l
4.3
4.2
0.06
102
739
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
649
1.56
3.48
3.6
3.0
e6/l
4.7
1.8
0.47
60
368
(3003327) Ova and parasites identified in Stool by Light microscopy
22
94
2.41
3.46
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
76
2.56
3.42
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
76
2.56
3.42
1.4
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
42
3.16
3.39
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
92
636
1.56
3.38
2.8
2.4
umol/l
12.3
12.5
0.07
85
591
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
14
5.79
3.35
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
43
3.08
3.27
1.1
2.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
173
1372
1.42
3.18
4.9
3.8
e6/l
125.3
152.0
0.09
136
1004
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
92
2.34
3.15
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
20
4.57
3.13
1.3
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
39
3.13
3.11
1.3
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
8
7.58
3.06
1.8
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
205
1.88
3.05
11.3
13.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
69
458
1.60
3.01
9.8
8.8
kpa
4.7
5.1
2.77
63
442
(3027801) Oxygen [Partial pressure] in Arterial blood
69
459
1.59
2.98
9.8
8.7
kpa
11.1
11.7
0.60
63
446
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
17
4.77
2.93
1.8
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
30
3.39
2.92
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
24
116
2.13
2.88
5.5
10.0
mmol/l
1.4
1.3
0.21
19
105
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
13
5.45
2.88
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
36
3.11
2.82
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
124
2.07
2.82
3.2
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
68
458
1.57
2.79
9.8
8.8
mmol/l
-0.3
1.3
1.58
51
367
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
111
2.13
2.78
1.9
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
162
1296
1.39
2.76
3.2
3.2
ng/l
2686.9
1531.6
0.62
146
1115
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
54
2.64
2.73
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
86
2.26
2.67
1.2
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
15
4.72
2.60
1.9
4.2
u/l
213.0
219.9
—
7
15
(40757373) Influenza virus identified in Isolate
5
7
7.21
2.55
2.0
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.21
2.55
1.8
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
31
173
1.85
2.53
3.0
3.2
pmol/l
4.1
4.4
1.07
26
154
(3037467) Urinalysis macro (dipstick) panel - Urine
286
2527
1.35
2.48
5.8
4.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
251
1.70
2.47
2.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
144
1149
1.37
2.44
3.5
3.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
27
3.38
2.40
1.8
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
59
2.42
2.31
1.6
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
47
2.59
2.29
1.5
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
13
4.66
2.28
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
323
1.58
2.23
3.8
3.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
36
2.82
2.21
1.4
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
42
2.66
2.20
1.2
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
49
2.49
2.12
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
189
1598
1.31
2.12
2.2
2.1
pmol/l
88.5
93.7
0.68
122
841
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
82
2.11
2.09
1.7
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.04
2.07
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
297
1.57
2.05
4.8
3.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
76
2.15
2.05
2.3
2.4
%
16.1
15.7
—
7
33
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
15
4.04
2.04
7.0
2.4
%
136.3
103.2
—
6
15
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
15
4.04
2.04
1.3
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
15
4.04
2.04
1.0
1.1
ug/l
10.1
9.2
—
6
15
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
311
3375
0.76
2.04
6.6
6.4
mmol/mol
40.3
40.7
0.38
288
3102
(3023410) Appearance of Cerebral spinal fluid
9
32
2.85
2.01
1.8
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
21
3.37
1.97
1.3
1.1
mmol/l
3.0
1.8
—
7
21
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
21
3.37
1.97
1.4
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
54
375
1.50
1.96
2.3
2.3
ug/g
177.6
136.7
0.42
45
304
(3017732) Neutrophils [#/volume] in Blood
36
228
1.63
1.94
2.1
2.9
e9/l
3.4
4.2
1.04
28
169
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
71
2.15
1.94
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
85
2.04
1.92
7.2
3.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
89
682
1.38
1.91
3.5
2.8
e6/l
1.1
1.1
0.07
56
396
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
95
1.93
1.78
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
24
2.95
1.73
1.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
13
3.88
1.72
1.8
1.7
ug/l
43.0
77.6
—
5
13
(3021960) Folate [Moles/volume] in Serum or Plasma
118
960
1.31
1.70
1.8
1.6
nmol/l
17.7
20.5
1.39
101
794
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
31
2.61
1.66
1.3
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
25
2.83
1.65
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
339
3604
0.77
1.61
6.0
5.2
mmol/l
2.7
2.6
1.16
316
3260
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
32
2.53
1.60
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
292
1.48
1.55
3.2
2.8
ml/min/173m2
67.6
61.4
0.36
17
114
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
33
2.45
1.54
1.3
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
15
3.36
1.52
4.6
5.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
27
2.62
1.52
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
329
3498
0.79
1.46
5.6
4.6
mmol/l
1.3
1.4
4.87
311
3162
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
39
2.33
1.43
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
88
704
1.31
1.43
1.3
1.2
u/ml
1.9
1.3
0.39
21
186
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
41
2.22
1.37
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
17
2.96
1.36
1.4
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
502
1.34
1.35
1.3
1.3
u/ml
1.0
15.2
3.24
29
177
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
281
2582
1.23
1.34
6.2
3.7
pmol/l
14.6
14.9
1.78
264
2294
(3023419) Bacteria identified in Sputum by Culture
12
61
1.99
1.34
7.7
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
43
2.11
1.31
3.1
3.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
186
1.54
1.30
1.2
1.2
iu/ml
72.4
115.8
—
5
68
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
44
2.07
1.27
2.2
3.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
122
1425
0.80
1.27
3.9
4.5
%
20.7
21.1
0.09
54
701
(3008898) HLA-B27 [Presence]
16
92
1.77
1.26
1.0
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
19
2.65
1.22
1.2
1.7
nmol/l
0.6
0.9
—
5
14
(3045788) Cell count panel - Pleural fluid
8
39
2.07
1.16
1.5
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
20
2.52
1.15
1.6
1.6
g/l
0.8
1.0
—
5
20
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
103
1.68
1.14
1.8
1.5
ug/g
269.8
262.2
0.07
12
55
(3007461) Platelets [#/volume] in Blood
379
3936
0.78
1.13
58.8
23.4
e9/l
218.7
240.1
6.22
372
3826
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
51
1.98
1.12
1.1
1.1
g/l
1.7
1.6
—
10
46
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
51
1.98
1.12
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
206
0.57
1.11
3.0
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
335
3523
0.82
1.11
6.6
4.7
mmol/l
4.5
4.5
0.40
320
3211
(3051651) Icteric interference index of Serum or Plasma
7
31
2.28
1.10
3.4
3.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
21
2.40
1.09
1.2
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
41
1.97
1.09
1.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
180
0.55
1.09
1.8
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
146
1.53
1.05
1.9
3.3
g/l
0.4
0.2
0.49
13
60
(3026361) Erythrocytes [#/volume] in Blood
380
3938
0.79
1.04
58.6
23.4
e12/l
4.2
4.5
16.74
373
3811
(3010813) Leukocytes [#/volume] in Blood
380
3938
0.79
1.04
58.6
23.5
e9/l
6.8
6.8
0.14
373
3812
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
22
2.29
1.03
2.4
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
48
1.89
1.01
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
157
0.56
1.00
1.7
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
276
1.37
0.99
5.2
6.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
35
260
1.37
0.96
7.3
8.2
mmol/l
24.3
24.6
0.16
30
247
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
447
1.29
0.96
1.5
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
70
575
1.26
0.95
25.1
25.0
inr
1.4
1.3
0.23
16
75
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1555
1.18
0.95
4.6
4.0
ng/l
35.5
40.0
0.32
134
1185
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
99
846
1.22
0.94
1.8
1.7
pmol/l
620.8
429.6
0.56
84
696
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
27
2.24
0.93
1.5
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
231
0.64
0.93
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
43
1.88
0.87
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
342
0.72
0.86
1.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
61
500
1.25
0.86
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
47
1.71
0.81
1.5
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
89
1027
0.83
0.80
2.8
3.1
ug/l
0.6
0.8
1.31
61
687
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
370
3564
1.20
0.80
43.5
16.2
mg/l
26.2
26.1
0.01
342
2893
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
162
1776
0.86
0.77
4.2
5.2
ug/l
2.4
2.8
0.21
147
1573
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
59
1.71
0.76
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24
176
1.38
0.74
2.5
3.4
u/ml
35.3
1773.7
1.04
18
149
(3000492) Spirometry study
41
330
1.27
0.69
1.7
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
440
1.23
0.69
2.1
4.4
ug/l
3.7
35.7
1.13
42
376
(3049717) Cytology report of Urine Cyto stain
25
189
1.34
0.66
3.4
2.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.2
3.1
u/ml
24.1
72.1
—
5
29
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
104
1.46
0.63
1.5
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
989
1.15
0.59
3.9
3.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
105
1164
0.87
0.58
3.1
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
470
0.81
0.57
20.0
7.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3013512) EKG study
131
1196
1.13
0.56
5.1
4.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
239
0.74
0.55
1.6
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
203
1907
1.12
0.54
3.0
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
342
3522
0.89
0.51
6.2
4.9
mmol/l
6.0
6.1
0.77
316
3167
(3009261) Glucose [Presence] in Urine by Test strip
192
1804
1.11
0.50
3.9
3.9
estimate
0.0
0.0
0.00
46
312
(3021601) Nitrite [Presence] in Urine by Test strip
189
1777
1.11
0.49
5.3
5.3
estimate
0.0
0.0
0.00
49
326
(4034850)
8
121
0.66
0.46
27.0
9.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
203
1.24
0.43
1.1
1.2
—
—
—
0
0
(4010399)
22
272
0.80
0.42
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
70
1.44
0.42
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
330
3390
0.91
0.41
6.7
4.2
mmol/l
1.5
1.3
3.94
314
3048
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
105
0.66
0.39
1.1
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
80
1.38
0.38
3.6
2.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
197
1.23
0.38
2.4
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
28
234
1.21
0.38
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
422
1.15
0.38
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
146
0.75
0.36
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
364
3714
0.90
0.36
33.1
15.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
370
3770
0.90
0.34
43.9
19.0
mmol/l
4.0
4.0
1.65
364
3664
(3035350) Ketones [Presence] in Urine by Test strip
186
1774
1.08
0.34
4.0
3.8
estimate
0.0
0.0
0.00
48
324
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
237
2282
1.08
0.34
5.9
3.3
u/l
76.7
55.5
1.53
222
2110
(3045414) Leukocytes [Presence] in Urine
17
139
1.23
0.29
1.8
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
370
3761
0.92
0.28
43.1
18.9
mmol/l
139.1
139.6
3.88
364
3656
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
539
1.11
0.28
1.3
1.3
iu/ml
9.9
41.0
6.25
17
168
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
117
0.76
0.27
1.2
1.7
nmol/l
40.4
43.5
—
9
111
(40768793) Breast Pathology biopsy report
8
67
1.20
0.26
1.6
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
269
2621
1.06
0.25
5.1
4.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
88
1.26
0.22
2.5
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
103
976
1.07
0.22
4.5
4.1
estimate
0.0
0.0
0.00
46
313
(4268621)
5
40
1.25
0.22
1.6
2.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
10
79
1.27
0.22
1.3
1.3
nmol/l
1.2
0.8
—
10
65
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
146
1401
1.06
0.22
4.3
4.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
103
0.77
0.21
2.5
1.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.7
—
0.7
—
0
12
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.2
—
321.7
—
0
7
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.7
—
4611.9
—
0
8
(3044007) Cell count panel - Peritoneal fluid
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.8
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
127
1.19
0.20
1.7
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
508
0.92
0.19
5.0
4.7
%
27.5
31.6
2.55
42
327
(3000475) Leukocytes [#/volume] in Synovial fluid
11
90
1.23
0.19
1.8
1.4
e6/l
7377.8
17851.7
0.80
11
71
(3012516) Albumin [Mass/volume] in Urine
122
1173
1.05
0.17
3.0
3.2
mg/l
454.9
163.4
0.37
73
764
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
4.9
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
76
0.79
0.15
1.2
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
78
1.16
0.15
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
807
0.94
0.15
4.3
4.2
kg/l
1.0
1.0
0.25
11
119
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
89
0.78
0.14
1.0
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
128
1243
1.04
0.12
3.8
3.9
mg/mmol
9.8
9.6
0.02
81
788
(3022621) pH of Urine by Test strip
27
249
1.09
0.12
2.6
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
125
0.88
0.10
3.6
5.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
197
0.91
0.10
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
369
1.06
0.10
1.7
1.7
%
1.4
1.6
1.43
33
315
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.8
4.7
umol/l
324.6
356.5
—
5
39
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.3
nmol/l
0.7
0.6
—
5
41
(1002224) Polysomnography panel
11
124
0.88
0.09
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
65
1.08
0.08
3.0
3.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
66
1.06
0.08
3.0
3.0
mmol/l
4.0
4.1
—
7
66
(3035285) Chloride [Moles/volume] in Venous blood
7
66
1.06
0.08
3.0
3.0
mmol/l
105.0
105.3
—
7
66
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
307
0.94
0.08
1.9
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
338
3404
0.97
0.07
34.7
14.9
ml/min/173m2
76.6
76.9
0.08
309
2812
(3014051) Protein [Presence] in Urine by Test strip
7
81
0.86
0.07
2.6
2.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
122
1208
1.01
0.02
3.0
3.1
mmol/l
7.5
7.6
0.15
97
989
(3020891) Body temperature
15
158
0.95
0.02
8.8
4.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
316
3169
0.99
0.01
37.1
17.2
%
37.3
39.7
3.58
215
2138
(40768800) Prostate Pathology biopsy report
10
106
0.94
0.01
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
209
1.01
0.00
3.6
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
322
3222
1.00
0.00
6.1
4.5
mu/l
1.9
2.0
0.92
304
2874
(3011397) Hemoglobin [Presence] in Urine by Test strip
82
821
1.00
0.00
3.4
3.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
97
971
1.00
0.00
2.1
1.6
mmol/l
1.7
1.3
2.17
88
799
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
110.0
—
0
8
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.6
—
0
8
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.0
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
78
0.90
0.00
1.1
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
20.4
—
0
9
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
3.2
nmol/l
3.9
7.2
—
5
52
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
23.3
—
0
7
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
-0.00
0.0
1.0
—
12.4
—
0
6
(44806071)
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_TNK_LYMPHOMA – Mature T/NK-cell lymphomas, hilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).